A series of triazolo-triazines was developed as adenosine receptor (AR) antagonists.
Compounds show better affinity at the hA2A and hA3 ARs than at the hA1 and hA2B ARs.
A benzylamino group at the C5 position gives highest affinity values at the hARs.
Docking simulations were carried out to explain the observed binding data.